The document outlines a comprehensive approach to quality risk management (QRM) in the pharmaceutical industry, detailing processes for risk assessment, evaluation, and control. It emphasizes the importance of systematic risk evaluation based on scientific knowledge to protect patient safety, while also providing tools and case studies for practical application. Key concepts include the definitions of risk and harm, as well as the structured steps involved in risk management, from identification to communication.